Back to All

Diaceutics Strengthens Advisory Team as it prepares for greater patient impact

17 December, 2018

 In this update, we highlight the company's efforts to strengthen its team of experts, enhancing its ability to navigate the complexities of precision medicine and diagnostic testing.

By expanding its advisory team, Diaceutics is poised to provide even greater support to pharmaceutical companies, diagnostic laboratories, and healthcare providers. This initiative reflects our commitment to improving patient outcomes through personalized treatment strategies.

Explore the full article to learn more about how Diaceutics is preparing for the future of precision medicine and advancing patient care.

Click here to view the full article

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane

Tel: +44 (0)20 3405 0205 or [email protected]

Caroline Forde
Robyn Fisher
Kieran Breheny